Raymond James & Associates Anika Therapeutics, Inc. Transaction History

Raymond James & Associates

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$32.49 - $45.96 $199,943 - $282,837	-6,154 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$32.59 - $45.26 $16,034 - $22,267	492 Added 8.69%	6,154 $279,000
Q3 2020 Nov 04, 2020	SELL	$32.56 - $38.57 $2,116 - $2,507	-65 Reduced 1.13%	5,662 $200,000
Q2 2020 Jul 28, 2020	BUY	$27.83 - $37.73 $159,382 - $216,079	5,727 New	5,727 $216,000
Q1 2020 Apr 21, 2020	SELL	$22.38 - $54.06 $132,153 - $319,224	-5,905 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$51.85 - $73.36 $3,007 - $4,254	-58 Reduced 0.97%	5,905 $306,000
Q3 2019 Nov 07, 2019	SELL	$40.05 - $57.47 $55,268 - $79,308	-1,380 Reduced 18.79%	5,963 $327,000
Q2 2019 Aug 06, 2019	SELL	$30.3 - $41.14 $11,453 - $15,550	-378 Reduced 4.9%	7,343 $298,000
Q1 2019 May 06, 2019	BUY	$29.37 - $40.49 $46,992 - $64,784	1,600 Added 26.14%	7,721 $233,000
Q4 2018 Feb 11, 2019	SELL	$30.16 - $43.0 $37,971 - $54,137	-1,259 Reduced 17.06%	6,121 $206,000
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $9,126 - $11,817	-278 Reduced 3.63%	7,380 $311,000
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $100,637 - $168,848	3,498 Added 84.09%	7,658 $245,000
Q1 2018 May 14, 2018	BUY	$49.22 - $68.43 $204,755 - $284,668	4,160 New	4,160 $207,000

123

11.5M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.